A Clinical Trial of EHT102 Injection in Pediatric Patients With Biallelic hOTOF Mutations

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Treatment of Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Eye & ENT Hospital of Fudan University, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Yilai Shu, M.D. & Ph.D.) · yilai_shu@fudan.edu.cn · +86 021 64377134

Study leads

Yilai Shu, M.D. & Ph.D.
Principal Investigator
Eye & ENT Hospital of Fudan University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants, Adolescents and Adults With Hearing Loss Due to Otoferlin Mutations

Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Los Angeles, United States · San Diego, United States